Fig. 4From: Network pharmacology modeling identifies synergistic interaction of therapeutic and toxicological mechanisms for Tripterygium hypoglaucum HutchThe PPI networks associating with the efficacy and toxicity of THH. Note: a: The PPI network of THH for treating rheumatoid arthritis (RA). b: The PPI network of THH for treating systemic lupus erythematosus (SLE). c: The PPI networks of THH induced adverse reactions (ADRs)Back to article page